Turner William D.
Chief Regulatory Officer
Turner William D. has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Feb 25, 2026.
On the most recent filing, Turner William D. is listed as Chief Regulatory Officer at Vera Therapeutics, Inc. Inside the rolling window, Turner William D. reported no open-market purchases and 4 open-market sales totaling $1.4M in VERA. The largest disclosed transaction in the window is a sale of 10,000 VERA shares on Dec 15, 2025, worth $501K.
Companies traded
Other insiders at VERA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Turner William D. made?
Turner William D. has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Turner William D. trade?
Turner William D. has filed SEC Form 4 disclosures for 1 company, including VERA.
When was Turner William D.'s most recent SEC Form 4 filing?
Turner William D.'s most recent SEC Form 4 filing on Tracefour is dated Feb 25, 2026.
What is Turner William D.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Turner William D. is listed as Chief Regulatory Officer.
What is Turner William D.'s total buy and sell value in the current window?
Inside the rolling retention window, Turner William D. bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Turner William D.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 VERA shares on 2025-12-15, worth $501K, per SEC Form 4 filings.